Drug Pipeline

Niacin 100 mg Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
4
Recruiting
5
Top Sponsors
Active Studies by Phase
Phase 2
2
Early Phase 1
2
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03540758 Regulation of Endogenous Glucose Production by Central KATP Channels Diabetes Mellitus Recruiting
NCT07306364 Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain Chronic Low Back Pain (CLBP) Not Yet Recruiting
Early Phase 1
NCT06175403 A Study of Niacin Regulation Excessive Weight Gain Recruiting
NCT06760533 Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS) IBS - Irritable Bowel Syndrome Not Yet Recruiting
Not specified
NCT05934409 Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic… Diabetes Mellitus Type 2 Recruiting
NCT06843148 Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Recruiting
Sponsors Running Niacin 100 mg Trials
Disease Areas
Get alerts when Niacin 100 mg trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free